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Abstract
Dengue fever represents a major public health problem. Both viral and host immune factors are involved in severe infections. Humans and
mosquito-vectors are infected with diverse viral populations that may play a role in viral adaptation and disease pathogenesis. Our objective
was to analyse the intra-host genetic variability of dengue virus type 1 (DENV-1) in the venous and capillary blood and its relationships with
the clinical presentation of dengue fever. Early serum samples were collected in 2009 from ten DENV-1-infected patients hospitalized in Santa
Cruz de la Sierra, Bolivia. Partial viral envelope sequences were analysed at the inter-host and intra-host level. For each patient, an average of
56 clone sequences was analysed both in the venous sector and the capillary sector (from right and left hands). The ten consensus sequences
were highly similar. The intra-host DENV-1 genetic variability was signiﬁcantly lower in the venous sector than in the capillary sector, and in
patients with haemorrhagic symptoms than in those without haemorrhagic symptoms, particularly in capillary samples. No relation was found
with sex, age, dengue IgG-serological status, day of serum sampling, or viral load. Signiﬁcant relationships were found between the clinical
presentation of dengue fever and the variability of viral populations within hosts, particularly in capillary samples. The observed variability of
envelope sequences at the early phase of dengue infection was not critically inﬂuenced by the previous dengue serological status of patients.
An important part of viral microevolution may occur in the capillary sector and inﬂuence the mechanisms of severe forms.
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Introduction
Dengue fever represents an increasing public health issue in
the tropics and subtropics [1]. Infection with one of the four
serotypes of dengue virus (DENV) can be subclinical or cause
mild febrile syndrome to severe illness with bleeding and
shock, providing a prolonged speciﬁc immunity against this
serotype but not against the others [2].
Two physiopathological hypotheses—which are not neces-
sarily exclusive—are debated, based on host immune factors
and viral virulence factors.
The antibody-dependent enhancement theory relies on the
observation that patients experiencing a second dengue
infection have a higher risk for developing severe disease [3].
Pre-existing heterologous dengue antibodies, induced by a
previous infection, would enhance the replication of DENV in
mononuclear cells that secrete vasoactive mediators causing
increased vascular permeability, hypovolaemia and shock.
Factors involving cell-mediated immunity and host genetics
have been shown to be determinants of disease severity [4,5].
Viral factors are also implicated. For example, several
studies have shown that DENV-2 viruses belonging to the
genotype ‘Southeast Asia’ have a higher virulence and epidemic
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potential than viruses belonging to the ‘American’ genotype
[6,7], and residue E-390 has been shown to be key in the level
of viral replication [8]. However, although genetic variations of
viral populations observed within human hosts and mosquito
vectors may play a role in viral adaptation to changing
environments, their role in dengue pathogenesis remains
unclear [9–18]. Relationships between DENV intra-host
genetic diversity and clinical outcome have rarely been studied
and results are conﬂicting [10,14,17,18].
Here, we analysed the intra-host envelope sequence
variations of DENV-1 for ten Bolivian patients hospitalized in
2009. Our objectives were to study the relationships between
DENV intra-host genetic variability and clinical presentation,
and to perform a detailed analysis of viral population genetics
not only in venous blood but also in the capillary blood, as the
latter may be implicated in the mechanisms of viral transmis-
sion and disease severity.
Materials and Methods
Serum sampling and data collection
Serum samples were collected from ten patients hospitalized for
DENV-1 infection at the ‘Hospital Universitario Japones’, Santa
Cruz de la Sierra, Bolivia, during the 2009 dengue outbreak. For
each patient, one venous and two capillary blood samples (right
and left foreﬁngers) were collected at the same time as
symptoms. One patient was sampled on two consecutive days.
Data collected included: age, sex, day of symptom onset and
serum sampling, presence of fever, headaches, retro-orbital
pain, myalgia/arthralgia, digestive symptoms, rash, spontaneous
bleeding, positive tourniquet test [19], hypotension, serous
effusion, thrombocytopenia and hypoalbuminaemia.
Ethics statement
This studywas performedwith the authorization of the ‘Hospital
Universitario Japones’ ethics review committee and the
informed verbal consent of all participants. Participation pro-
vided access to rapid biological diagnosis of dengue (see below).
Laboratory experiments
Dengue diagnosis was conﬁrmed by rapid immunochromato-
graphic test (Ag NS1/IgG/IgM Dengue Duo Rapid Test,
PANBIO diagnostics, Brisbane, Australia), IgM detection
(Panbio Dengue IgM Capture ELISA) and RT-PCR using
pan-dengue and DENV-1 speciﬁc techniques.
Viral loadswere quantiﬁed by real-timeRT-PCR, as described
previously [20], using phage MS2 as an internal control [21].
Secondary infections were identiﬁed through dengue-
speciﬁc IgG detection (Panbio Dengue IgG Capture ELISA).
To study intra-host variations of envelope sequences, viral
RNA was extracted, ampliﬁed cloned and sequenced from one
venous and two capillary samples from each patient. Viral RNA
was extracted using the BioRobot EZ1 workstation with the
VirusMini Kit v2.0 (Qiagen, Hilden, Germany). A 758-nucleotide
fragment within the E-gene was ampliﬁed using the AccuScript
PfuUltra II RT-PCR Kit (Agilent Technologies, Stratagene, La
Jolla, CA, USA) and speciﬁc primersQ1F andQ1R [17]. RT-PCR
products were puriﬁed (QIA quick gel extraction kit, Qiagen),
ligated into the pCR II cloning vector and transformed into
TOP10 competent cells (Dual Promoter TA Cloning kit,
Invitrogen, Carlsbad, CA, USA). The blue-white colour screen-
ing method was used to select transformed colonies.
Sequencing was performed using the T7 promoter primer
(5′-TAATACGACTCACTATAGGG-3′). Sequences of ‘hyper-
mutant clones’ were controlled in the sense and reverse
directions using both T7 and SP6 (5′-ATTTAGGTGACACT
ATAGAA-3′) primers.
Phylogeny and sequence analysis
Sequences were analysed and edited using the SEQUENCHER 4.7
software (Gene Codes Corporation, Ann Arbor, MI).
Sequences were aligned using CLUSTAL W and trimmed so
that they contained 758 nucleotides encoding 252 amino acids,
including portions of domain I and II, the complete domain III,
and a portion of the stem-anchor region, as previously
described [17]. Phylogenetic and molecular evolutionary
analyses were performed using the MEGA 4.0.2 package [22]
(see footnotes of Figures and Tables for details).
Statistical analyses
All statistical analyses were performed using the R software
package (R development Core Team version 2.9.1) with
p-values below 0.05 indicating statistical signiﬁcance. Variables
reﬂecting the genetic variability of DENV-1 at the intra-host
level were compared according to several variables: sex and
age, presence of haemorrhagic symptoms (positive tourniquet
test and/or spontaneous bleeding), immunological status
(positive or negative dengue-speciﬁc IgG antibodies), day of
serum sampling, sample origin (venous or capillary) and viral
load. Results were compared using a Student’s t-test or a
Mann–Witney U-test. Correlation analyses were performed
using a Spearman’s rank correlation test.
Results
Characteristics of the population studied
Ten patients were studied (Table 1). Fever and headaches were
present in all patients, retro-orbital pain in seven patients,
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myalgia/arthralgia in eight patients, digestive symptoms in four
patients, rash in two patients, and haemorrhagic symptoms in
ﬁve patients. There was no case of hypotension or death.
The sex ratio, age, day of serum sampling, proportion of
primary/secondary dengue infection, and viral loads were
similar in patients with or without haemorrhagic symptoms.
Viral loads were not correlated with the day of serum
sampling, and were similar in venous and capillary samples
from left or right hand, and in primary or secondary infection.
Phylogenetic analysis of DENV-1 strains
All patients included in this study were infected by DENV-1
strains belonging to the genotype V ‘America-Africa’ (Fig. 1).
These strains isolated during the 2009 Bolivian outbreak
constitute a homogeneous group of sequences.
Genetic variability of DENV-1 at the inter-host and intra-host
level
The ten consensus envelope sequences were highly similar
with ten nucleotides and three amino acid mutations. Patients
14, 25, 29 and 40 experiencing different clinical presentations
shared the same consensus sequence, whereas mutations were
observed in other patients (four synonymous and three
non-synonymous: F429C (patient 46), K291R and A331E
(patient 30), according to the D1.Indonesia/88 envelope
numbering (GenBank accession number AB074761).
To study the extent of genetic variability within patients
(intra-host level), an average of 56 clones per patient was
analysed. The global analysis including all clones from venous and
capillary samples showed that DENV-1 populations were
composed of one dominant viral population and a number of
variants that could be detected early during infection (Table 2).
Despite a lower viral genetic diversity at the intra-host level than
at the inter-host level, more non-synonymous mutations were
present within patients than among them (pN = 67% versus
30%, and mean dN/dS = 0.737 versus 0.125, respectively).
At the intra-host level, most mutations corresponded to
single substitutions leading to amino acid changes in 67% of
cases and occurring all along the studied E-protein region
(amino acids E190–441). Some mutations were shared by
several clones from the capillary sector (e.g. E362G (domain
III) in two capillary clones from patient 35 and 25, G416R
(membrane-anchor domain) in three capillary clones from
patient 35). Three deletions leading to the appearance of a
stop codon were observed in two clones (patient 46, capillary
sample). In-frame stop codons were identiﬁed in nine clones
(none of them at amino acid position E248 [16]).
Different patterns of viral populations in the venous and
capillary sectors
The mutation patterns were analysed according to the blood
sample origin. A higher frequency of mutant clones, a higher
TABLE 1. Clinical and biological characteristics of the study population
Serum number Sex Age (years)
Day of serum
sampling
Dengue
infection
Viral load (Ct)
Venous
sample
Capillary sample
(left hand)
Capillary sample
(right hand)
Patients without haemorrhagic symptoms
25 (day 2) Male 13 2 Secondary 28.80 26.99 30.08
25 (day 3) Male 13 3 Secondary 28.00 24.00 28.03
28 Male 42 2 Primary 16.83 23.00 22.00
35 Female 23 2 Secondary 20.65 22.00 22.00
40 Male 29 4 Primary 24.00 30.00 29.60
46 Female 10 2 Primary 20.79 26.00 25.00
Min 10 2 16.83 22.00 22.00
Max 42 4 28.80 30.00 30.08
Mean 22 3 23.18 25.33 26.12
Med 18 2 22.40 25.00 26.52
Patients with haemorrhagic symptoms*
14 Female 20 3 Primary 30.58 36.00 26.20
29 Male 12 4 Primary 21.68 25.50 25.00
30 Male 46 3 Secondary 21.96 23.00 23.00
49 Male 27 3 Secondary 22.97 25.00 27.00
76 Male 21 3 Primary 19.58 24.00 30.00
Min 12 3 19.58 23.00 23.00
Max 46 4 30.58 36.00 30.00
Mean 25 3 23.35 26.70 26.24
Med 21 3 21.96 25.00 26.20
*Positive tourniquet test in four cases, purpura in one case, epistaxis in two cases, conjunctival haemorrhage in one case, thrombocytopenia with a platelet count lower than
100 G/L in three cases (ranging from 67 to 79 G/L), and equal to 140 G/L in one patient with positive tourniquet test, epistaxis and conjunctival haemorrhage.
Five patients with haemorrhagic symptoms were compared with ﬁve patients without haemorrhagic symptoms including one patient with sequential samples (Patient 25). Early
venous and capillary blood sampling was performed at the same time of symptoms for each patient, between day 2 and day 4 (day 1 is the day of symptoms onset).
No signiﬁcant differences were found between patients with or without haemorrhagic symptoms (sex ratio and the proportion of primary/secondary infection in each group were
compared using a t-test; age, day of serum sampling and viral loads were compared using a Mann–Witney test).
Viral load estimated using cycle threshold (Ct) values were not correlated with the day of serum sampling (using a Spearman method), and were similar in patients with primary or
secondary infection (using a Mann–Witney test). Ct values were not signiﬁcantly different in venous and capillary samples from left or right hand (using a t-test or a Mann–Witney
test).
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D1 Bolivia 391/02 (E2001)
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D1 Bolivia 289/02 (2001)
D1 Bolivia 221/02 (E2001)
D1 Bolivia 119/02 (E2001)
D1 Bolivia 273/02 (E2001)
D1 Bolivia 25/99 (E1998)
D1 Bolivia JR-38/99 (E1998)
D1 Bolivia JR-16/99 (E1998)
D1 Bolivia JR-22/99 (E1998)
D1 Brazil 409/97 (AF311957)
D1 Brazil 111/97 (AF311956)
D1 Brazil 233/97 (AF311958)
D1 Brazil/01(AF513110)
D1 Argentina 297/00 (AF514889)
D1 Paraguay 259par00/00
D1 Argentina 295arg00/00 
D1 Argentina 301/00 (AF514876)
D1 Brazil/90 (AF226685)
D1 Nicaragua BID/V614/05
D1 Venezuela/95 (AF425635)
D1 Bolivia 1868/08 (E2007)
D1 Puerto Rico BID/V852/06
D1 Venezuela BID/V1135/07
D1 Venezuela BID/V1136/07
D1 Bolivia 1877/08 (E2007)
D1 Bolivia 2370/08 (E2007)
D1 Bolivia 2575/08 (E2007)
D1 Bolivia 2369/08 (E2007)
D1 Bolivia 2009 (49)
D1 Bolivia 2009 (76)
D1 Bolivia 2009 (29)
D1 Bolivia 2009 (14)
D1 Bolivia 2009 (25)
D1 Bolivia 2009 (40)
D1 Bolivia 2009 (28)
D1 Bolivia 2009 (35)
D1 Bolivia 2009 (30)
D1 Bolivia 2009 (46)
D1 Angola/88 (AF425610)
D1 Costa Rica/93 (AY153755)
D1 Jamaica PRS-288690/77 
D1 Aruba 495-1/85 
D1 French Guyana/89 (AF226687)
D1 French Polynesia/89 (AY630408)
D1 Colombia/85 (AF425623)
D1 Trinidad/86 (AF425639)
D1 Colombia/96 (AF425617)
D1 Peru/91 (AF425626)
D1 Argentina 297/00 (AF514889)
D1 Paraguay 280/00 (AF514878)
D1 Singapore 275/90 (M87512)
D1 Nigeria/68 (AF425625)
D1 Malaysia/72 (AF425622)
D1 Thailand/54 (D10513)
D1 Nauru/74 (U88535)
D1 Philippines/84 (D00503)
D1 Thailand/80 (D00502)
D1 Australia/83 (AF425612) 
D1 Indonesia/88 (AB074761)
D1 French Polynesia/01 (DQ672558)
D1 Indonesia/98 (AB189120)
D1 Cambodia/98 (AF309641)
D1 Djibouti/98 (AF298808)
D3
D4
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99
99
99
99
99
99
99
79
96
99
99
99
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FIG. 1. Phylogenetic tree based on 68 nucleotide sequences of partial E-gene of dengue virus (DENV) (neighbour-joining method, Kimura 2
algorithm). The consensus tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the
phylogenetic tree. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are
shown next to the branches. Taxon names of the 2009 Bolivian strains correspond to D1 Bolivia 2009 with the patient number in brackets. Taxon
names of Bolivian strains previously characterized [23] correspond to D1 Bolivia patient number/last two digits of year of isolation, and the epidemic
year (E) in brackets. Taxon names of GenBank sequences correspond to D1.country/last two digits of year of isolation. Their GenBank accession
numbers are indicated in brackets. All patients included in this study were infected by DENV-1 strains belonging to the genotype V ‘America-Africa’.
These strains isolated during the 2009 Bolivian outbreak constitute a homogeneous group of sequences sharing a common ancestor with Bolivian
strains involved in the 2007 outbreak that share themselves a common ancestor with strains isolated in Puerto Rico (2006) and Venezuela (2007).
The 2007 and 2009 Bolivian strains are more distantly related to Bolivian strains from the 1998, 2000 and 2001 outbreaks characterized by E-gene
sequences highly similar to those of viruses that circulated in Brazil and Argentina during the same period [23]. The 2009 Bolivian DENV-1 viruses
may have evolved in situ in Bolivia after the introduction of new variants in 2007 from neighbouring countries (Puerto Rico, Venezuela).
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genetic diversity (percentage of mutations) and divergence
(p-distances) were observed in capillary samples (Table 3,
p 0.04, 0.03, 0.04 for nucleotide sequences, respectively)
suggesting a higher genetic variability in the capillary sector
than in the venous sector. The proportion of non-synonymous
mutations was similar in both sectors.
Three clone sequences from capillary samples of patients 46
(no haemorrhagic signs) and 76 (haemorrhagic signs) were
characterized by a high variability. Their sequences were
checked and conﬁrmed by cloning control experiments and
sequencing in both directions. Viral loads measured in their
respective origin samples were not speciﬁcally high in
comparison with other samples.
The comparison of venous and capillary results was also
conducted after excluding these ‘hypermutant clones’ from
samples 46L, 46R and 76L. Similar results were obtained with
higher viral genetic variability in the capillary sector, albeit only
signiﬁcant for mean and maximal p amino acids.
Viral loads were signiﬁcantly lower in capillary samples than
in venous samples (p 0.03). However, variables reﬂecting the
studied intra-host genetic variability of DENV-1 were not
correlated with viraemia.
Relationship between intra-host DENV-1 genetic variability
and clinics
The composition of DENV-1 populations was different among
infected patients. The proportion of mutant clones, the genetic
diversity and divergence were signiﬁcantly lower in patients
with haemorrhagic symptoms than in those without haemor-
rhagic symptoms, both in nucleotide and amino acid sequences
(Fig. 2). These differences were particularly signiﬁcant in the
capillary sector, whether sequences of hypermutant clones
were excluded or not from analysis (see Supplementary
material, Table S1).
The studied intra-host genetic variability did not signiﬁcantly
correlate with age, sex, host immune status, time of serum
sampling or viral load.
Discussion
The variability of DENV-1 envelope sequences was analysed
within patients infected by strains belonging to a homogeneous
group of viruses. This study shows that, in human hosts, DENV-1
populations are composed of one dominant viral population and
a number of variants characterized by a sequence variability
that is signiﬁcantly associated with the presence of haemor-
rhagic signs, particularly in capillary blood samples.
Relationships between the genetic variability of RNA viruses
and the clinical presentation or course of disease have been
reported already, particularly in chronic infections. It is now
well known that patients are infected with HIV-1 viral
populations made of a dynamic swarm of mutants commonly
called ‘quasispecies’. This can be explained by a high viral
TABLE 2. Dengue type 1 virus (DENV-1) genetic variability at the inter-host and intra-host level in ten Bolivian patients (2009
outbreak)
Genetic
diversity Genetic divergence
pN (%) dN dS dN/dS
% of
mutations p nt p aa
nt aa Min Max Mean Min Max Mean
Inter-host level 0.13 0.12 0.000 0.005 0.003 0.000 0.012 0.002 30 0.001 0.008 0.125
Intra-host level
Patient 14 0.00 0.01 0.000 0.001 0.000 0.000 0.004 0.000 100 0.000 0.000 1.000
Patient 25 (day2) 0.03 0.07 0.000 0.006 0.001 0.000 0.014 0.001 73 0.001 0.001 1.000
Patient 25 (day3) 0.02 0.05 0.000 0.009 0.001 0.000 0.026 0.001 75 0.001 0.000 1.000
Patient 28 0.03 0.07 0.000 0.004 0.001 0.000 0.013 0.001 83 0.001 0.000 1.000
Patient 29 0.00 0.01 0.000 0.001 0.000 0.000 0.000 0.000 100 0.000 0.000 1.000
Patient 30 0.01 0.02 0.000 0.003 0.000 0.000 0.008 0.000 60 0.000 0.000 1.000
Patient 35 0.02 0.05 0.000 0.003 0.000 0.000 0.008 0.001 73 0.000 0.001 0.000
Patient 40 0.01 0.04 0.000 0.004 0.000 0.000 0.011 0.001 83 0.000 0.000 1.000
Patient 46 0.05 0.03 0.000 0.013 0.001 0.000 0.008 0.001 19 0.000 0.003 0.000
Patient 49 0.01 0.01 0.000 0.003 0.000 0.000 0.006 0.000 50 0.000 0.000 1.000
Patient 76 0.12 0.07 0.000 0.071 0.002 0.000 0.033 0.001 19 0.001 0.009 0.111
Min 0.00 0.01 0.000 0.001 0.000 0.000 0.000 0.000 19 0.000 0.000 0.000
Max 0.12 0.07 0.000 0.071 0.002 0.000 0.033 0.001 100 0.001 0.009 1.000
Mean 0.03 0.04 0.000 0.011 0.001 0.000 0.012 0.001 67 0.000 0.001 0.737
Median 0.02 0.04 0.000 0.004 0.000 0.000 0.008 0.001 73 0.000 0.000 1.000
To assess the genetic variability of DENV-1 between patients (inter-host level), the ten consensus sequences of viruses were aligned and analysed. To assess the genetic variability
of DENV-1 within patients (intra-host level), an average of 56 clone sequences per patient was analysed (range = 52–63, median = 55) both in the venous sector (~ 20 clones) and
the capillary sector (~ 20 clones from right hand, ~ 20 clones from left hand). Patient 25 was sampled on two consecutive days (grey lines, day 2 and day 3).
The extent of genetic diversity was evaluated using the percentage of mutations among the nucleotide (nt) sequences and the amino acid (aa) sequences (number of nt and aa
mutations/number of nt and aa sequenced). The extent of genetic divergence was evaluated using the pairwise distance among the nt sequences (p nt) and the aa sequences (p aa).
The proportion of non-synonymous mutations was pN = number of aa mutations/number of nt mutations. The mean ratio of non-synonymous (dN) to synonymous (dS)
substitutions per site was estimated using the pairwise method of Nei and Gojobori as implemented in the MEGA 4.0.2 package [22]. In pairwise comparisons in which there were
no synonymous substitutions, dN/dS was set at 1.000.
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replication and error rates of reverse transcriptase, recombi-
nation events and host selection pressures. The intra-host viral
genetic diversity can vary according to viral factors (e.g.
differences in virulence or replication capacity), and host
properties (e.g. genetic factors or gender). In several studies,
patients with low pretreatment HIV envelope diversity showed
delayed disease progression and stronger immune responses
than rapid progressors [23–25]. On the other hand, greater
genetic diversity was observed in children with slow than with
rapid disease development [26]. Considering hepatitis C, most
studies concluded that high quasispecies diversity correlated
with more severe liver disease [27,28].
The importance of quasispecies dynamics is also suspected
in acute viral infections such as mosquito-borne ﬂaviviral
TABLE 3. Different patterns of dengue virus type 1 (DENV-1) viral populations in the venous and capillary sectors
Serum number No of clones Viral load (Ct value)
% of mutant
clones
Genetic
diversity Genetic divergence
nt aa
% of
mutations p nt p aa
nt aa Max Mean Max Mean
Venous sector
25 day 2 20 28.80 15 15 0.03 0.08 0.005 0.001 0.014 0.002
25 day 3 19 28.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
28 19 16.83 11 11 0.01 0.04 0.003 0.000 0.004 0.000
29 20 21.68 0 0 0.00 0.00 0.000 0.000 0.000 0.000
30 23 21.96 13 4 0.02 0.02 0.003 0.000 0.004 0.000
35 20 20.65 10 5 0.01 0.02 0.003 0.000 0.000 0.000
46 19 20.79 0 0 0.00 0.00 0.000 0.000 0.000 0.000
49 18 22.97 0 0 0.00 0.00 0.000 0.000 0.000 0.000
76 17 19.58 0 0 0.00 0.00 0.000 0.000 0.000 0.000
40 18 24.00 6 6 0.01 0.02 0.001 0.000 0.000 0.000
14 20 30.58 5 5 0.01 0.02 0.001 0.000 0.004 0.000
Min 17 16.83 0 0 0.00 0.00 0.000 0.000 0.000 0.000
Max 23 30.58 15 15 0.03 0.08 0.005 0.001 0.014 0.002
Median 19 21.96 5 4 0.01 0.02 0.001 0.000 0.000 0.000
Mean 19 23.26 5 4 0.01 0.02 0.001 0.000 0.002 0.000
Capillary sector
25L day 2 17 26.99 18 18 0.03 0.08 0.006 0.001 0.010 0.001
25R day 2 15 30.08 20 7 0.03 0.03 0.005 0.001 0.007 0.001
25L day 3 19 24.00 11 5 0.01 0.02 0.003 0.000 0.007 0.001
25R day 3 14 28.03 21 21 0.06 0.15 0.009 0.002 0.026 0.003
28L 18 23.00 28 28 0.04 0.13 0.004 0.001 0.008 0.003
28R 17 22.00 24 12 0.03 0.05 0.003 0.001 0.004 0.000
29L 17 25.50 0 0 0.00 0.00 0.000 0.000 0.000 0.000
29R 17 25.00 6 6 0.01 0.02 0.001 0.000 0.000 0.000
30L 20 23.00 5 5 0.01 0.02 0.001 0.000 0.004 0.000
30R 20 23.00 5 5 0.01 0.02 0.002 0.000 0.005 0.000
35L 20 22.00 25 10 0.03 0.06 0.003 0.001 0.008 0.001
35R 19 22.00 21 21 0.03 0.08 0.003 0.001 0.008 0.002
46L 20 26.00 30 25 0.09 0.07 0.013 0.002 0.008 0.001
46R 20 25.00 5 5 0.06 0.02 0.012 0.001 0.004 0.000
49L 18 25.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
49R 17 27.00 12 6 0.02 0.03 0.003 0.000 0.006 0.000
76L 20 24.00 20 20 0.32 0.18 0.070 0.006 0.033 0.004
76R 18 30.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
40L 20 30.00 10 5 0.01 0.02 0.003 0.000 0.004 0.001
40R 18 29.60 17 17 0.02 0.07 0.004 0.000 0.011 0.001
14L 19 36.00 5 5 0.01 0.02 0.001 0.000 0.004 0.000
14R 20 26.20 0 0 0.00 0.00 0.000 0.000 0.000 0.000
Min 14 22.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
Max 20 36.00 30 28 0.32 0.18 0.070 0.006 0.033 0.004
Median 19 25.25 11 6 0.02 0.02 0.003 0.000 0.006 0.001
Mean 18 26.06 13 10 0.04 0.05 0.007 0.001 0.007 0.001
Results after excluding three ‘hypermutant clones’ from samples 46L, 46R and 76L
46L 19 26.00 26 16 0.02 0.04 0.003 0.000 0.008 0.001
46R 19 25.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
76L 19 24.00 11 11 0.02 0.05 0.002 0.000 0.005 0.001
Min 14 22.00 0 0 0.00 0.00 0.000 0.000 0.000 0.000
Max 20 36.00 28 28 0.06 0.15 0.009 0.002 0.026 0.003
Median 19 25.25 11 6 0.02 0.03 0.003 0.000 0.005 0.001
Mean 18 26.06 12 9 0.02 0.04 0.003 0.000 0.006 0.001
Statistical results (using a Mann–Witney test to compare venous and capillary values) with all clones included
p-value 0.20 0.03 0.04 0.04 0.03 0.05 0.05 0.04 0.02 0.04
After excluding three “hypermutant clones” from samples 46L, 46R and 76L
p-value 0.20 0.03 0.07 0.07 0.07 0.09 0.17 0.16 0.03 0.04
For each patient, a similar number of clone sequences from one venous and two capillary blood samples (left foreﬁnger ‘L’ and right foreﬁnger ‘R’) were aligned and analysed. The
percentage of mutant clones, the genetic diversity and divergence are signiﬁcantly higher in the capillary sector than in the venous sector, both at the nucleotide (nt) and the amino
acid (aa) levels. The minimum p-distances (min p nt and min p aa) are not indicated in the table as all are equal to zero.
Three clone sequences from capillary samples of patients 46 and 76 (grey lines) are characterized by a high variability. When sequences of these ‘hypermutant clones’ are excluded,
the overall viral genetic variability remains higher in the capillary sector, but is only signiﬁcant for mean and maximal p aa. Ct values are signiﬁcantly higher in capillary samples than
in venous samples (indicating lower viral loads). However, there is no signiﬁcant correlation between variables reﬂecting the studied intra-host genetic variability of DENV-1 and
the Ct values (using a Spearman method).
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diseases. Flaviviruses exhibit genetic variability that may be
involved in their adaptation to changing environments in
alternated hosts/vectors and in disease pathogenesis [9–
18,29,30]. Ciota et al. [29] have shown that the E/NS1 region
genetic diversity of West Nile virus increased with serial
passage in C6/36 mosquito cell culture and that the viral
replicative ability in mosquito cells was positively correlated
with the mutant spectrum size. Studies relating to dengue
infection are rare and include few patients and clones, with
contrasted ﬁndings. Different DENV genome regions have
been analysed from venous blood collected in patients infected
with different serotypes. In three DENV-3 studies performed
in Taiwan, the mean amino acid p-distance in the E-NS1 region
was signiﬁcantly higher in patients with dengue haemorrhagic
fever than in those with dengue fever [14] whereas the
intra-host genetic diversity observed in the envelope (E) [9],
capsid (C) and non-structural (NS2B) genes [10] was similar in
dengue haemorrhagic fever and dengue fever cases. In another
study focusing on a 462-nucleotide region carrying domain III
of the envelope in serial plasma samples taken from 17
patients, no relationship was found between the extent and
pattern of DENV-1 genetic diversity and disease severity,
immune status, or level of viraemia [18]. In the largest study
performed to date, considering approximately 40 clones/
serum from 16 patients infected with DENV-1 in French
Polynesia (FP 2001-2006), we observed that the envelope gene
sequence variability (in a 758-nucleotide region including
portions of domains I and II, the complete domain III, and a
portion of the stem-anchor region) was signiﬁcantly lower in
severe cases (dengue haemorrhagic fever and/or dengue shock
syndrome) than in classical cases (dengue fever) [17].
Reminiscent of the French Polynesia study [17], the current
study in DENV-1-infected Bolivian patients showed that viral
populations were more homogeneous in patients with haem-
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FIG. 2. Dengue virus type 1 (DENV-1) genetic variability in patients with and without haemorrhagic symptoms. The extent of intra-host genetic
variability of DENV-1 based on the global analysis of clone sequences (average 56 clones/patient) from both venous and capillary sectors was
compared between ﬁve patients with haemorrhagic symptoms and ﬁve patients without haemorrhagic symptoms using a Mann–Witney test. The
percentage of mutant clones (number of clones with nucleotide (nt) and amino acid (aa) mutation/total number of clones), the percentage of
mutations among nt and aa sequences (number of nt and aa mutations/number of nt and aa sequenced), the pairwise distance (p-distance) among nt
sequences (p nt) and among aa sequences (p aa) presented as boxplots (with central line indicating the median value) on the left axes, respectively,
were calculated using the MEGA 4.0.2 package [22]. All parameters of genetic variability were signiﬁcantly lower in patients with haemorrhagic
symptoms (p <0.05 using a Mann–Witney test), except mean p nt. Detailed results of the analysis restricted to the venous sector and the capillary
sector are presented in the Supplementary material, Table S1.
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orrhagic symptoms than in those without, even when haem-
orrhagic presentations were mild, sometimes limited to a
positive tourniquet test. However, this test is a reliable clinical
method to assess the capillary fragility and the patient’s
haemorrhagic tendency [19]. Although the small sample size of
this study and the use of cloning (which limits the depth of
variability analysis) are limitations, our results are of speciﬁc
interest in comparison with previous studies because (1) a high
number of clones was analysed, using a high-ﬁdelity ampliﬁca-
tion system with a thermostable Pfu polymerase before
cloning, so reducing the risk of in vitro overestimation of
genetic variability; (2) there was balanced distribution of
primary/secondary infections in patients with or without
haemorrhagic symptoms; (3) biological sampling occurred
early (day 2–4).
Our results provide new insights to understand dengue
pathogenesis. First, the capillary sector has been investigated
and viral population genetics has been compared in the venous
and capillary blood for the ﬁrst time, to our knowledge. This is
relevant as the capillary blood is involved in viral transmission
between human-hosts and mosquito-vectors and in the
mechanisms of severe dengue whereas the venous blood
contains circulating viral populations that are produced in
different host tissues. Although viral loads were lower in
capillary samples, we found that the envelope genetic variabil-
ity was higher in the capillary blood and not correlated with
viral load. In support of previous ﬁndings in French Polynesia
[17], we found a lower viral genetic variability in patients with
haemorrhagic symptoms. This remarkable observation sug-
gests that the dynamics of viral populations within hosts and
their genetic diversity may be connected with dengue patho-
genesis. The observation of more homogeneous viral popula-
tions in patients with haemorrhagic symptoms and in the
venous blood may reﬂect a more efﬁcient viral replication of
speciﬁc variants, which may lead to an enhanced host immune
response favouring disease severity. The nature, diversity and
load of viruses replicating in the capillary sector may obviously
play a role in the mechanisms of capillary leakage and bleeding.
Another major observation is that, in the studied group, the
genetic variability was not signiﬁcantly different according to the
dengue-speciﬁc IgG serological status of patients. This suggests
that the viral envelope variability observed within hosts is not
critically inﬂuenced by their previous immune status, at least at
the early stage of dengue infection. These ﬁndings may be
signiﬁcant issues in the perspective of vaccine development.
In conclusion, the pathogenesis of severe forms of dengue
should not be restricted to host immune mechanisms as
relationships between clinical presentation and dengue genet-
ics have been repeatedly identiﬁed. Our results highlight the
importance of studying dengue genetics in their intra-host
diversity and in different compartments (e.g. capillary sector).
Studying consensus sequences of viruses circulating in the
venous blood is not sufﬁcient for in-depth investigation of viral
virulence. Further studies including a higher number of infected
patients experiencing different forms of dengue infection and
sequential venous and capillary blood samples are obviously
required to further characterize the mechanisms underlying
these important observations. New technical procedures (e.g.
New Generation Sequencing methods) should be carefully
evaluated for that purpose and will provide in the future a
more accurate characterization of viral populations during
dengue infection.
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